[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4

N/A

Report date: 2026/05/12 20:00:17

NME

Base Information

Drug Name[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4

Drug Alias Name[Lys(40)(Ahx-DTPA-(111)In)NH(2)]-Exendin-4

ClassificationRadiation-emitting products > Nuclides > Indium > 111InRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionGlucagon-like peptide 1 receptor agonists

TargetsGlucagon-like peptide 1 receptor

Therapy Area/IndicationsInsulinoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Basel

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Basel

Inactive CompaniesN/A

Active IndicationsInsulinoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A